Aim: Medical biotechnology is one of the newest fields of biotechnology which has been underlie the dramatic changes in diagnosis and treatment of various diseases. This topic is a new plan in our country. The purpose of this study is to review the most important strategies of Europe :::union:::, America and Canada and provide practical solution for Iran.
Methods: This is a non-systematic review study which has been conducted in 2016. This review was based on Scoping Review methodology. Studied indicators in this study include economic and educational. Data was collected through review of library texts, internet searches and direct referral to the relevant organizations.
Results: The income of biotechnology companies have increased 80 percent and the costs of R&D in these centers have increased 5 percent. The remarkable point is the net income growth of 37 percent in 2012 compared to last year. Results shows that commercial leaders ahead of public & other companies in Financial indices. The status of biotechnology industry in The US was observed better than Canada and Europe :::union:::. Regarding the status of educational indices in the biotechnology industry, the number of MBA subjects seems more than the number of biotechnology and medical biotechnology subjects.
Conclusion: Support the establishment of private institutions and encourage them to look at the knowledge gained from biotechnology with economic, industrial and global marketing thinking as well as acceding to the global laws of intellectual property and global trade can be underlie entering the biotechnology industry arena and global market which the experts of this industry and technology will play an effective in this arena.